Harmony Biosciences Holdings, Inc. (HRMY)
38.56
+0.69
(+1.82%)
USD |
NASDAQ |
Jan 09, 16:00
38.56
0.00 (0.00%)
After-Hours: 18:10
Harmony Biosciences Holdings EPS Diluted (Quarterly): 0.8663 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | -0.2918 |
| West Pharmaceutical Services, Inc. | 1.928 |
| Castle Biosciences, Inc. | -0.0172 |
| Nurix Therapeutics, Inc. | -1.027 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 50.86M |
| Revenue (Quarterly) | 239.46M |
| Total Expenses (Quarterly) | 188.59M |
| Enterprise Value | 1.736B |
| Gross Profit Margin (Quarterly) | 72.60% |
| Profit Margin (Quarterly) | 21.24% |
| Earnings Yield | 8.23% |
| Operating Earnings Yield | 10.01% |
| Normalized Earnings Yield | 8.235 |